The safety of sodium-glucose co-transporter 2 inhibitors in patients with left ventricular assist device - a single center experience.

Moady, Gassan; Ben Avraham, Binyamin; Aviv, Shaul; Itzhaki Ben Zadok, Osnat; Atar, Shaul; Abu Akel, Mahmood; Ben Gal, Tuvia

Moady, Gassan; Ben Avraham, Binyamin; Aviv, Shaul; Itzhaki Ben Zadok, Osnat; Atar, Shaul; Abu Akel, Mahmood; Ben Gal, Tuvia.

Affiliation

Moady G; Department of Cardiology, Galilee Medical Center, Nahariya.
Ben Avraham B; Azrieli Faculty of Medicine, Bar Ilan University, Safed.
Aviv S; Heart Failure Unit, Cardiology Department, Rabin Medical Center.
Itzhaki Ben Zadok O; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Atar S; Heart Failure Unit, Cardiology Department, Rabin Medical Center.
Abu Akel M; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ben Gal T; Heart Failure Unit, Cardiology Department, Rabin Medical Center.

J Cardiovasc Med (Hagerstown) ; 24(10): 765-770, 2023 10 01.

Article de En | MEDLINE | ID: mdl-37577871

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Dispositifs d'assistance circulatoire / Diabète de type 2 / Inhibiteurs du cotransporteur sodium-glucose de type 2 Type d'étude: Diagnostic_studies Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: J Cardiovasc Med (Hagerstown) Sujet du journal: ANGIOLOGIA / CARDIOLOGIA Année: 2023 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google